Related Experiment Video

Updated: May 5, 2026

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

11.7K

The search for ESR1 mutations in breast cancer

Steffi Oesterreich1, Nancy E Davidson

  • 1Department of Pharmacology and Chemical Biology and Department of Medicine, University of Pittsburgh, Women's Cancer Research Center, University of Pittsburgh Cancer Institute and UPMC Cancer Center, and Magee-Womens Research Institute, Pittsburgh, Pennsylvania, USA.

Nature Genetics
|November 26, 2013
PubMed

Insights

Activating ESR1 gene mutations were found in metastatic breast cancers resistant to aromatase inhibitors. This discovery offers new strategies for managing endocrine-resistant breast cancer.

Area of Science:

  • Oncology
  • Genetics
  • Endocrinology

Background:

  • Metastatic breast cancer often develops resistance to endocrine therapies like aromatase inhibitors.
  • Estrogen receptor 1 (ESR1) gene mutations are increasingly recognized as a mechanism of resistance.

Discussion:

  • Two recent studies identified activating ESR1 mutations in patients with aromatase inhibitor-resistant metastatic breast cancer.
  • These mutations can lead to ligand-independent estrogen receptor activation, bypassing the need for estrogen.

Key Insights:

  • The identification of specific ESR1 mutations provides a molecular basis for understanding therapeutic resistance.
  • This finding highlights the importance of genetic profiling in advanced breast cancer.

Outlook:

  • Targeting ESR1 mutations may offer novel therapeutic strategies for endocrine-resistant breast cancer.
  • Further research is needed to develop and validate treatments that specifically address ESR1-mutated tumors.

More Related Videos

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.9K
Detection of Rare Mutations in CtDNA Using Next Generation Sequencing11:11

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

15.0K

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
5.7K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.5K